The mutations of KRAS and NRAS induce the activation of ERK are common in MM, and these mutations present in 23-54% with a new diagnosis, but it increases to 45-81% in RRMM patients [90–92]. This evidence concerns the gene NRAS and Miyoshi myopathy.